loading...| Preferred Name | Etidronate Disodium | |
| Synonyms |
|
|
| Definitions |
A synthetic therapeutic diphosphonate analogue of endogenous pyrophosphate. As a member of the family of drugs known as bisphosphonates, etidronate disodium differs from endogenous pyrophosphate in its resistance to enzymatic hydrolysis. This agent adsorbs to hydroxyapatite cells and reduces the number of osteoclasts, thereby inhibiting abnormal bone resorption. Etidronate may also directly stimulate bone formation by osteoblasts. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C831 |
|
| Accepted_Therapeutic_Use_For |
hypercalcemia of malignancy. |
|
| CAS_Registry |
7414-83-7 |
|
| Chemical_Formula |
C2H6O7P2.2Na |
|
| code |
C831 |
|
| Contributing_Source |
FDA |
|
| definition |
A synthetic therapeutic diphosphonate analogue of endogenous pyrophosphate. As a member of the family of drugs known as bisphosphonates, etidronate disodium differs from endogenous pyrophosphate in its resistance to enzymatic hydrolysis. This agent adsorbs to hydroxyapatite cells and reduces the number of osteoclasts, thereby inhibiting abnormal bone resorption. Etidronate may also directly stimulate bone formation by osteoblasts. (NCI04) |
|
| FDA_UNII_Code |
M16PXG993G |
|
| Has_Free_Acid_Or_Base_Form | ||
| in_subset | ||
| label |
Etidronate Disodium |
|
| Legacy Concept Name |
Etidronate_Disodium |
|
| Preferred_Name |
Etidronate Disodium |
|
| prefixIRI |
NCIT:C831 |
|
| prefLabel |
Etidronate Disodium |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C0037507 |
|
| subClassOf |